[1]
|
Wang, Y., Liu, J., Wang, W., et al. (2015) Lifetime Risk for Cardiovascular Disease in a Chinese Population: The Chi-nese Multi-Provincial Cohort Study. European Journal of Preventive Cardiology, 22, 380-388.
https://doi.org/10.1177/2047487313516563
|
[2]
|
Feinberg, J., Nielsen, E.E., Greenhalgh, J., et al. (2017) Drug-Eluting Stents versus Bare-Metal Stents for Acute Coronary Syndrome. Cochrane Database of Systematic Reviews, 8, CD012481.
https://doi.org/10.1002/14651858.CD012481
|
[3]
|
Mauri, L., Silbaugh, T.S., Garg, P., et al. (2008) Drug-Eluting or Bare-Metal Stents for Acute Myocardial Infarction. The New England Journal of Medicine, 359, 1330-1342. https://doi.org/10.1056/NEJMoa0801485
|
[4]
|
王振, 徐通达, 李东野. 冠心病合并糖尿病经皮冠状动脉介入治疗术后支架内再狭窄预测因素分析[J]. 安徽医药, 2019, 23(9): 1821-1825. https://doi.org/10.3969/j.issn.1009-6469.2019.09.031
|
[5]
|
Kuntz, R.E. and Baim, D.S. (1993) Defining Coronary Restenosis. Newer Clinical and Angiographic Paradigms. Circulation, 88, 1310-1323. https://doi.org/10.1161/01.CIR.88.3.1310
|
[6]
|
颜安. 中性粒细胞/淋巴细胞比值对冠脉介入术后支架内再狭窄的预测价值分析[D]: [硕士学位论文]. 通辽: 内蒙古民族大学, 2020.
|
[7]
|
Ma, J., Liu, X., Qiao, L., et al. (2021) Association between Stent Implantation and Progression of Nontarget Lesions in a Rabbit Model of Atherosclerosis. Circulation: Cardiovascular Interventions, 14, e010764.
https://doi.org/10.1161/CIRCINTERVENTIONS.121.010764
|
[8]
|
Komiyama, H., Takano, M., Hata, N., et al. (2015) Neoatherosclerosis: Coronary Stents Seal Atherosclerotic Lesions but Result in Making a New Problem of Ath-erosclerosis. World Journal of Cardiology, 7, 776-783.
https://doi.org/10.4330/wjc.v7.i11.776
|
[9]
|
Lee, S.W., Lee, J.Y., Ahn, J.M., et al. (2013) Comparison of Dual versus Triple Antiplatelet Therapy after Drug-Eluting Stent According to Stent Length (from the Pooled Analysis of DECLARE Trials). American Journal of Cardiology, 112, 1738-1744. https://doi.org/10.1016/j.amjcard.2013.08.008
|
[10]
|
Otsuka, F., Finn, A.V., Yazdani, S.K., et al. (2012) The Im-portance of the Endothelium in Atherothrombosis and Coronary Stenting. Nature Reviews Cardiology, 9, 439-453. https://doi.org/10.1038/nrcardio.2012.64
|
[11]
|
Cutlip, D.E., Windecker, S., Mehran, R., et al. (2007) Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions. Circulation, 115, 2344-2351. https://doi.org/10.1161/CIRCULATIONAHA.106.685313
|
[12]
|
Salfati, E., Nandkeolyar, S., Fortmann, S.P., et al. (2015) Susceptibility Loci for Clinical Coronary Artery Disease and Subclinical Coronary Atherosclerosis throughout the Life-Course. Circulation: Cardiovascular Genetics, 8, 803-811.
https://doi.org/10.1161/CIRCGENETICS.114.001071
|
[13]
|
Zhuo, Z.L., Xian, H.P., Long, Y., et al. (2018) Associ-ation between CYP2C19 and ABCB1 Polymorphisms and Clopidogrel Resistance in Clopidogrel-Treated Chinese Pa-tients. The Anatolian Journal of Cardiology, 19, 123-129.
https://doi.org/10.14744/AnatolJCardiol.2017.8097
|
[14]
|
Zheng, D., Mingyue, Z., Wei, S., et al. (2018) The Inci-dence and Risk Factors of In-Stent Restenosis for Vertebrobasilar Artery Stenting. World Neurosurgery, 110, e937-e941. https://doi.org/10.1016/j.wneu.2017.11.112
|
[15]
|
齐静, 邹德玲. 2型糖尿病患者冠状动脉支架内再狭窄的危险因素分析[J]. 医学综述, 2020, 26(16): 3303-3307.
|
[16]
|
Cassese, S., Byrne, R.A., Tada, T., et al. (2014) Incidence and Predictors of Restenosis after Coronary Stenting in 10004 Patients with Surveillance Angiography. Heart, 100, 153-159. https://doi.org/10.1136/heartjnl-2013-304933
|
[17]
|
Shlofmitz, E., Iantorno, M. and Waksman, R. (2019) Restenosis of Drug-Eluting Stents: A New Classification System Based on Disease Mechanism to Guide Treatment and State-of-the-Art Review. Circulation: Cardiovascular Interventions, 12, e007023. https://doi.org/10.1161/CIRCINTERVENTIONS.118.007023
|
[18]
|
黄自明, 郭观华, 彭俊, 等. 置入DES与BMS病人术后支架血栓发生率的差异及其影响因素分析[J]. 中西医结合心脑血管病杂志, 2017, 15(16): 2037-2039. https://doi.org/10.3969/j.issn.1672-1349.2017.16.027
|
[19]
|
Yadav, M., Mintz, G.S., Généreux, P., et al. (2019) The Smoker’s Paradox Revisited: A Patient-Level Pooled Analysis of 18 Randomized Controlled Trials. JACC: Cardiovascular Interventions, 12, 1941-1950.
https://doi.org/10.1016/j.jcin.2019.06.034
|
[20]
|
翟娜, 张宇静, 王明毅, 等. 药物洗脱支架与裸金属支架治疗无保护左主干病变的效果比较[J]. 中国当代医药, 2015, 22(3): 55-58, 61.
|
[21]
|
Kastrati, A., Dibra, A., Mehilli, J., et al. (2006) Predictive Factors of Restenosis after Coronary Implantation of Sirolimus- or Paclitaxel-Eluting Stents. Circula-tion, 113, 2293-2300.
https://doi.org/10.1161/CIRCULATIONAHA.105.601823
|
[22]
|
赵全明. 冠心病患者经皮冠状动脉介入术后支架内再狭窄的认识现状[J]. 心肺血管病杂志, 2017, 36(8): 611-612, 620. https://doi.org/10.3969/j.issn.1007-5062.2017.08.001
|
[23]
|
Shlofmitz, E., Kuku, K.O., Waksman, R. and Gar-cia-Garcia, H.M. (2019) Intravascular Ultrasound-Guided Drug-Eluting Stent Implantation. Minerva Cardioangiologica, 67, 306-317. https://doi.org/10.23736/S0026-4725.19.04895-3
|
[24]
|
Ullrich, H., Olschewski, M., Münzel, T. and Gori, T. (2021) Coronary In-Stent Restenosis: Predictors and Treatment. Deutsches Ärzteblatt International, 118, 637-644. https://doi.org/10.3238/arztebl.m2021.0254
|
[25]
|
Araki, M., Park, S.J., Dauerman, H.L., Uemura, S., Kim, J.S., Di Mario, C., et al. (2022) Optical Coherence Tomography in Coronary Atherosclerosis Assessment and Interven-tion. Nature Reviews Cardiology, 19, 684-703.
https://doi.org/10.1038/s41569-022-00687-9
|
[26]
|
Jones, D.A., Rathod, K.S., Koganti, S., Hamshere, S., Astrou-lakis, Z., Lim, P., et al. (2018) Angiography Alone versus Angiography plus Optical Coherence Tomography to Guide Percutaneous Coronary Intervention: Outcomes from the Pan-London PCI Cohort. JACC: Cardiovascular Interventions, 11, 1313-1321.
https://doi.org/10.1016/j.jcin.2018.01.274
|
[27]
|
Nerlekar, N., Cheshire, C.J., Verma, K.P., et al. (2017) Intravascu-lar Ultrasound Guidance Improves Clinical Outcomes during Implantation of both First- and Second-Generation Drug-Eluting Stents: A Meta-Analysis. EuroIntervention, 12, 1632-1642. https://doi.org/10.4244/EIJ-D-16-00769
|